Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | BRD4 | O60885 | 2/20 | 0.34 |
| ▸ | BRD2 | P25440 | 1/20 | 0.34 |
| ▸ | ERN1 | O75460 | 3/20 | 0.34 |
| ▸ | MLYCD | O95822 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21226236 | 0.78 | ERN1 (0.32) | GAALMNASMN1; SMN2BRD4BRD2 | |
| SCHEMBL16140189 | 0.76 | ERN1 (0.33) | GAALMNASMN1; SMN2BRD4ERN1 | |
| SCHEMBL31416480 | 0.69 | LMNA (0.30) | GAALMNASMN1; SMN2 | |
| SCHEMBL3088412 | 0.68 | PTGS2 (0.58) | GAALMNASMN1; SMN2BRD4BRD2 | |
| SCHEMBL2198294 | 0.65 | LMNA (0.32) | GAALMNASMN1; SMN2BRD4BRD2 | |
| SCHEMBL20604742 | 0.65 | — | — | |
| SCHEMBL14691254 | 0.65 | EDNRA (0.33) | — | |
| SCHEMBL18172305 | 0.65 | — | — | |
| SCHEMBL12486 | 0.64 | — | — | |
| SCHEMBL14275197 | 0.60 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2300 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113929674-B | Compound containing 1, 4-dihydro quinazoline structure, preparation method and application thereof | 中国药科大学 | 2023-09-22 | — | — | CN | claimed |
| US-20230219976-A1 | AMORPHOUS SOLID FORM OF A BET PROTEIN INHIBITOR | INCYTE CORPORATION | 2023-07-13 | — | — | US | claimed |
| CN-108250191-B | 3, 5-disubstituted 2-amino-pyrazine compound and preparation process and application thereof | 兰州大学 | 2020-10-20 | — | — | CN | claimed |
| CN-110563713-A | 4-phenyl substituted isoxazole compound and application thereof in antihistamine medicine | 王兴理 | 2019-12-13 | — | — | CN | claimed |
| US-10329305-B2 | Amorphous solid form of a BET protein inhibitor | INCYTE CORPORATION (US) | 2019-06-25 | — | — | US | claimed |
| US-20180273546-A1 | AMORPHOUS SOLID FORM OF A BET PROTEIN INHIBITOR | INCYTE CORPORATION | 2018-09-27 | — | — | US | claimed |
| US-20170121347-A1 | AMORPHOUS SOLID FORM OF A BET PROTEIN INHIBITOR | INCYTE CORPORATION | 2017-05-04 | — | — | US | claimed |
| WO-2017075377-A1 | AMORPHOUS SOLID FORM OF A BET PROTEIN INHIBITOR | INCYTE CORPORATION (US) | 2017-05-04 | — | — | WO | claimed |
| EP-1831206-B1 | N-SUBSTITUTED BENZIMIDAZOLYL C-KIT INHIBITORS AND COMBINATORIAL BENZIMIDAZOLE LIBRARY | OSI PHARM INC (US) | 2011-08-24 | — | — | EP | claimed |
| JP-2008521903-A | — | — | 2008-06-26 | — | — | JP | claimed |
| EP-1831206-A2 | N-SUBSTITUTED BENZIMIDAZOLYL C-KIT INHIBITORS AND COMBINATORIAL BENZIMIDAZOLE LIBRARY | OSI Pharmaceuticals, Inc. (US) | 2007-09-12 | — | — | EP | claimed |
| WO-2006060381-A2 | N-SUBSTITUTED BENZIMIDAZOLYL C-KIT INHIBITORS AND COMBINATORIAL BENZIMIDAZOLE LIBRARY | OSI PHARMACEUTICALS, INC. (US) | 2006-06-08 | — | — | WO | claimed |
| US-20060116402-A1 | N-substituted benzimidazolyl c-Kit inhibitors and combinatorial benzimidazole library | OSI PHARMACEUTICALS, INC. | 2006-06-01 | — | — | US | claimed |
| US-12637426-B2 | 1-cyano-pyrrolidine compounds as USP30 inhibitors | MISSION THERAPEUTICS LIMITED (GB) | 2026-05-26 | — | — | US | disclosed |
| CN-122055371-A | Faster automated iterative C-C bond formation | 伊利诺伊大学评议会 | 2026-05-15 | — | — | CN | disclosed |
| US-20260103459-A1 | SUBSTITUTED AZACYLES AS TRPM8 MODULATORS | GIVAUDAN SA (CH) | 2026-04-16 | — | — | US | disclosed |
| WO-2001032625-A1 | ARYL- AND HETEROARYL-SUBSTITUTED TETRAHYDROISOQUINOLINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE AND SEROTONIN | DU PONT PHARMACEUTICALS COMPANY (US) | 2001-05-10 | — | — | WO | disclosed |
| WO-2001016120-A1 | BIARYL-OXA(THIA)ZOLE DERIVATIVES AND THEIR USE AS PPARS MODULATORS | ELI LILLY AND COMPANY (US) | 2001-03-08 | — | — | WO | disclosed |
| WO-2001016121-A1 | HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF | MERCK & CO., INC. (US) | 2001-03-08 | — | — | WO | disclosed |
| WO-2001000213-A1 | SRC KINASE INHIBITOR COMPOUNDS | MERCK & CO., INC. (US) | 2001-01-04 | — | — | WO | disclosed |